- Home
- WRAP vs ENTX Comparison
WRAP vs ENTX Comparison
Compare WRAP & ENTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WRAP
- ENTX
- Stock Information
- Founded
- WRAP 2016
- ENTX 2010
- Country
- WRAP United States
- ENTX Israel
- Employees
- WRAP N/A
- ENTX N/A
- Industry
- WRAP Ordnance And Accessories
- ENTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WRAP Industrials
- ENTX Health Care
- Exchange
- WRAP Nasdaq
- ENTX Nasdaq
- Market Cap
- WRAP 73.3M
- ENTX 104.0M
- IPO Year
- WRAP N/A
- ENTX 2018
- Fundamental
- Price
- WRAP $1.54
- ENTX N/A
- Analyst Decision
- WRAP
- ENTX Strong Buy
- Analyst Count
- WRAP 0
- ENTX 1
- Target Price
- WRAP N/A
- ENTX $10.00
- AVG Volume (30 Days)
- WRAP 215.0K
- ENTX 33.0K
- Earning Date
- WRAP 05-15-2025
- ENTX 08-08-2025
- Dividend Yield
- WRAP N/A
- ENTX N/A
- EPS Growth
- WRAP N/A
- ENTX N/A
- EPS
- WRAP N/A
- ENTX N/A
- Revenue
- WRAP $3,796,000.00
- ENTX $223,000.00
- Revenue This Year
- WRAP N/A
- ENTX N/A
- Revenue Next Year
- WRAP N/A
- ENTX N/A
- P/E Ratio
- WRAP N/A
- ENTX N/A
- Revenue Growth
- WRAP N/A
- ENTX N/A
- 52 Week Low
- WRAP $1.30
- ENTX $1.41
- 52 Week High
- WRAP $2.58
- ENTX $2.79
- Technical
- Relative Strength Index (RSI)
- WRAP 49.49
- ENTX 43.51
- Support Level
- WRAP $1.51
- ENTX $1.84
- Resistance Level
- WRAP $1.64
- ENTX $2.02
- Average True Range (ATR)
- WRAP 0.09
- ENTX 0.14
- MACD
- WRAP -0.01
- ENTX -0.01
- Stochastic Oscillator
- WRAP 18.75
- ENTX 14.71
About WRAP Wrap Technologies Inc.
Wrap Technologies Inc is a public safety technology and services company that delivers safe and effective policing solutions to law enforcement and security personnel worldwide. The firm develops policing solutions to law enforcement and security personnel. Its BolaWRAP 150 Remote Restraint device is a patented, hand-held tool that discharges a Kevlar cord to restrain noncompliant individuals from a range of 10-25 feet. The group operates in the Americas, Europe, the Middle East, Africa and the Asia Pacific.
About ENTX Entera Bio Ltd.
Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.